28 real series b-stage Healthtech pitch decks with teardowns and measured benchmarks: median 15 slides, 12–19 typical, verified round sizes.
Series B Healthtech Pitch Deck Examples & Benchmarks
Every published Healthtech teardown whose own filed stage note says series b — 28 decks from 28 companies. The benchmarks below are measured from exactly those decks.
Measured on 28 published teardowns (28 companies) — the same decks listed on this page. Slide counts and years come from each deck's own filed facts; round sizes only from rounds we could verify. Decks missing a figure are excluded from that figure's denominator rather than counted as zero.
The measured numbers
Decks in this cohort: 28 — 28 companies, each with a published teardown
Median deck length: 15 slides — Middle half runs 12–19 slides (28 decks with a slide count)
Median verified raise: $44.5M — 28 of 28 decks have a verified round size
Decks from 2022 or later: 4 of 27 — 4 predate 2018; 1 state no year
What the numbers say
Half of these decks run between 12 and 19 slides, with a median of 15. The shortest is 4 slides and the longest 36.
That median matches the wider Healthtech & Biotech collection (15 slides across 238 decks).
15 of the 28 decks with a verified round raised $10M–$50M, the most common band here. Every deck in this cohort has a verified round size.
The cohort is split evenly across eras: 4 decks from 2022 or later and 4 from before 2018, with 19 in between.
Where slides tend to land
Slide-level labelling covers too few decks in this cohort to describe a running order, so no sequence is shown. Deck length and round size above are measured from every deck listed.
Every one of the 28 decks in this cohort has a verifiable round size, and the median is $44.5M.
Series B in healthcare is a scaling round with a documented number behind it — this is the one cohort where the raise data is complete.
What to do with it: Benchmark your ask directly against this figure and be ready to justify a material deviation.
Median length is 15 slides, with the middle half between 12.5 and 19 — the same shape as healthtech overall.
The deck does not get longer at Series B; the evidence inside each slide gets heavier.
What to do with it: Do not add slides. Replace the early-stage promises with measured results in the same structure.
27 of the 28 decks have labelled slides, but the cohort is too small to publish a reliable slide-order table.
We would rather show nothing than publish a sequence built on 27 decks and let it read as a rule.
What to do with it: Use the healthtech-wide ordering as your structural guide, and this page for round-size and length benchmarks.
Limitation: No slide-sequence table is published for this cohort because the sample is too small.
What a Series B reader is testing
Series B guidance published by the sources below, plus the regulatory backdrop specific to healthcare.
Series B is where go-to-market fit is tested. Carta describes Series B as the point where you show go-to-market fit so you can invest more heavily in what is already working, and flags burn multiple as a key attractiveness signal. (Carta 2023)
The market repriced Series B. Carta measured the median US Series B on its platform at $15.1M in Q3 2023 — a 39.8% decline from Q1 2021. Healthcare rounds in our cohort run larger, which makes the capital-intensity argument something you have to make explicitly. (Carta 2023)
Check sizes have kept tightening. Carta's Q2 2025 data shows average check sizes down at every stage from Series A through Series D, with declines of 3% to 9%, and deal count down 10% across the first half. (Carta 2025)
Burn and efficiency. Burn multiple, explicitly. Carta names it as an attractiveness signal at this stage. (Carta 2023)
Ask and the scaling plan. Median raise in this cohort is $44.5M; say what capacity yours buys.
Material that usually belongs in an appendix rather than the main deck: cohort retention tables; payer contract summaries; trial data and publications; org plan by function.
Series B healthtech decks worth reading
Covers and commentary only; each links to the full teardown.
Tia. A care-model deck that carries both clinical outcomes and unit economics. Read the Tia deck teardown
Every Series A promise is closed out. The deck states what was promised, what happened, and what it cost.
One channel is shown compounding. Breadth reads as uncertainty at this stage; depth reads as fit.
Efficiency is volunteered. Burn multiple appears before the investor asks for it.
Series B mistakes in this cohort
Growth without efficiency. Carta explicitly ties attractiveness at this stage to a low burn multiple. Instead: Put burn multiple and payback next to the growth chart. (Carta 2023) Basis: Cited investor data.
Assuming 2021 round sizes. Carta measured Series B medians down 39.8% from Q1 2021, with check sizes still tightening through Q2 2025. Instead: Model the round you can raise now, and show the milestone it still reaches. (Carta 2023, Carta 2025) Basis: Cited market data.
All 28 decks in this cohort have a verifiable round size, and the median is $44.5M.
How does that compare to Series B generally?
Carta measured the median US Series B on its platform at $15.1M in Q3 2023, down 39.8% from Q1 2021. Healthcare rounds in our cohort run considerably larger, which is worth explaining rather than assuming. (Carta 2023)
How long should a Series B deck be?
Median 15 slides here, with the middle half between 12.5 and 19 — the same length as earlier-stage healthtech decks.
Why is there no slide-order table on this page?
Only 27 of the 28 decks have labelled slides. That is too small a base to publish a sequence without it reading as a rule, so we do not publish one.
What single metric matters most at Series B?
Carta points to go-to-market fit and a low burn multiple as what makes a company attractive at this stage. (Carta 2023)
Methodology and limitations
The cohort is the 28 published deck teardowns on this page (published Series B healthtech deck teardowns). Nothing outside that set is counted, and the set is frozen so the numbers on this page do not move under you.
Slide counts come from the original deck file, not from a summary or a re-typed copy.
Slide-type positions are only computed over the 27 decks in this cohort whose slides are labelled. That is why every row shows "found in X of Y decks" rather than a percentage — a percentage would imply the other decks lack the slide, when in fact we simply have not labelled them.
Round sizes are the amounts publicly reported for the round the deck was used for; decks with no verifiable amount are excluded from that statistic rather than estimated.
External claims on this page link to the publisher that made them, with the date we checked the page. We do not restate a third-party number without a link to its own source.
We publish deck covers and link to each teardown. We do not republish slides from these decks.
